Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 1/2021

01-04-2021 | Metastasis | Case Report

Functional Malignant Retroperitoneal Paraganglioma with Liver Metastasis: a Rare Case Report

Authors: Sachin S. Kadam, Sujai Hegde, Amol Galage, Tejaswini Kadam

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2021

Login to get access

Abstract

Paragangliomas are rare neoplasms. Their specific annual incidence is still unclear. These are rare neuroendocrine tumors which arise from extra-adrenal paraganglioma and they have the ability to secrete catecholamines. Most of them are diagnosed in the 3rd to 5th decades of life with mean age around 47 years. Majority of them are benign; however, malignant tumors with metastatic behavior are very rare. The incidence of malignant paraganglioma is estimated around 93/400 million people. The clinical course of metastatic malignant disease is variable and the reported 5-year survival is around 12–84%. There is no curative treatment option for malignant metastatic paraganglioma. If resectable, both, primary and metastasis should be resected. The only criteria which defines its malignancy is the presence of metastatic spread of chromaffin cells in tissues that normally do not contain such cells. Functional paraganglioma secretes excessive catecholamines which clinically manifest as paroxysmal hypertension, headache, sweating, and palpitations. We reported a case of young male who presented with huge left retroperitoneal mass and after evaluation found to have a functional malignant paraganglioma with liver metastasis. Surgical resection of the primary malignant paraganglioma with metastatectomy helps in decreasing the complications, improving the symptoms and prolonging the survival.
Literature
1.
go back to reference Beard CM, Sheps SG, Kurland LT et al (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58:802PubMed Beard CM, Sheps SG, Kurland LT et al (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58:802PubMed
2.
go back to reference Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39:775–783CrossRef Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39:775–783CrossRef
3.
go back to reference Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210–5216CrossRef Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF Jr (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210–5216CrossRef
4.
go back to reference Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–R276CrossRef Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–R276CrossRef
5.
go back to reference Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C (2012) Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer 118:2804–2812CrossRef Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C (2012) Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer 118:2804–2812CrossRef
6.
go back to reference Strajina V, Dy BM, Farley DR, Richards ML, McKenzie TJ, Bible KC, Que FG, Nagorney DM, Young WF, Thompson GB (2017) Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series. Ann Surg Oncol 24:1546–1550CrossRef Strajina V, Dy BM, Farley DR, Richards ML, McKenzie TJ, Bible KC, Que FG, Nagorney DM, Young WF, Thompson GB (2017) Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series. Ann Surg Oncol 24:1546–1550CrossRef
7.
go back to reference Ayadi-Kaddour A, Braham E, Ismail O, Smati B, Djilani H, El Mezni F (2009) Posterior mediastinal paragangliomas: a report of three patients with peculiar tumors. Respirology 14(3):459–446CrossRef Ayadi-Kaddour A, Braham E, Ismail O, Smati B, Djilani H, El Mezni F (2009) Posterior mediastinal paragangliomas: a report of three patients with peculiar tumors. Respirology 14(3):459–446CrossRef
8.
go back to reference Gonzalez-Santos JM, Arnaiz-Garcia ME, Munoz-Herrera A, Lopez-Rodriguez J (2016) Mediastinal paraganglioma fed by the left circumflex artery. Interact Cardiovasc Thorac Surg 23(5):835–836CrossRef Gonzalez-Santos JM, Arnaiz-Garcia ME, Munoz-Herrera A, Lopez-Rodriguez J (2016) Mediastinal paraganglioma fed by the left circumflex artery. Interact Cardiovasc Thorac Surg 23(5):835–836CrossRef
9.
go back to reference WHO Classification of Tumours (2004) Pathology and genetics of tumours of the endocrine organs DeLellis RA, Lloyd RV, Heitz PU, Eng C, IARC press: Lyon WHO Classification of Tumours (2004) Pathology and genetics of tumours of the endocrine organs DeLellis RA, Lloyd RV, Heitz PU, Eng C, IARC press: Lyon
10.
go back to reference Neumann HPH, Young WF Jr, Eng C (2019) Pheochromocytoma and paraganglioma. N Engl J Med 381:552–565CrossRef Neumann HPH, Young WF Jr, Eng C (2019) Pheochromocytoma and paraganglioma. N Engl J Med 381:552–565CrossRef
11.
go back to reference Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol A, Tischler AS, International Symposium on Pheochromocytoma (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92 Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol A, Tischler AS, International Symposium on Pheochromocytoma (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92
12.
go back to reference Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI, Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K (2016) PET/CT comparing (68)GaDOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 43:1784–1791CrossRef Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI, Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K (2016) PET/CT comparing (68)GaDOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 43:1784–1791CrossRef
13.
go back to reference Strajina V, Dy BM, Farley DR, Richards ML, McKenzie TJ, Bible KC, Que FG, Nagorney DM, Young WF, Thompson GB (2017) Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series. Ann Surg Oncol 24:1546–1550CrossRef Strajina V, Dy BM, Farley DR, Richards ML, McKenzie TJ, Bible KC, Que FG, Nagorney DM, Young WF, Thompson GB (2017) Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series. Ann Surg Oncol 24:1546–1550CrossRef
14.
go back to reference Teno S, Tanabe A, Nomura K, Demura H (1996) Acutely exacerbated hypertension and increased inflammatory signs due to radiation treatment for metastatic pheochromocytoma. Endocr J 43:511–516CrossRef Teno S, Tanabe A, Nomura K, Demura H (1996) Acutely exacerbated hypertension and increased inflammatory signs due to radiation treatment for metastatic pheochromocytoma. Endocr J 43:511–516CrossRef
15.
go back to reference Hidaka S, Hiraoka A, Ochi H, Uehara T, Ninomiya T, Miyamoto Y, Hasebe A, Tanihira T, Tanabe A, Ichiryu M, Nakahara H, Tazuya N, Ninomiya I, Michitaka K (2010) Malignant pheochromocytoma with liver metastasis treated by transcatheter arterial chemoembolization (TACE). Intern Med 49:645–651CrossRef Hidaka S, Hiraoka A, Ochi H, Uehara T, Ninomiya T, Miyamoto Y, Hasebe A, Tanihira T, Tanabe A, Ichiryu M, Nakahara H, Tazuya N, Ninomiya I, Michitaka K (2010) Malignant pheochromocytoma with liver metastasis treated by transcatheter arterial chemoembolization (TACE). Intern Med 49:645–651CrossRef
16.
go back to reference Noto RB, Pryma DA, Jensen J, Lin T, Stambler N, Strack T, Wong V, Goldsmith SJ (2018) Phase 1 study of high-specific-activity I-131 MIBG for metastatic and/or recurrent pheochromocytoma or paraganglioma. J Clin Endocrinol Metab 103:213–220CrossRef Noto RB, Pryma DA, Jensen J, Lin T, Stambler N, Strack T, Wong V, Goldsmith SJ (2018) Phase 1 study of high-specific-activity I-131 MIBG for metastatic and/or recurrent pheochromocytoma or paraganglioma. J Clin Endocrinol Metab 103:213–220CrossRef
17.
go back to reference Cecchin D, Schiavi F, Fanti S, Favero M, Manara R, Fassina A, Briani C, Allegri V, Sansovini M, Bui F, Paganelli G, Opocher G (2011) Peptide receptor radionuclide therapy in a case of multiple spinal canal and cranial paragangliomas. J Clin Oncol 29:e171CrossRef Cecchin D, Schiavi F, Fanti S, Favero M, Manara R, Fassina A, Briani C, Allegri V, Sansovini M, Bui F, Paganelli G, Opocher G (2011) Peptide receptor radionuclide therapy in a case of multiple spinal canal and cranial paragangliomas. J Clin Oncol 29:e171CrossRef
18.
go back to reference Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J (2010) 177Lu[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy. Cancer 116:1084–1092CrossRef Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J (2010) 177Lu[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: analysis of dosimetry with impact on future therapeutic strategy. Cancer 116:1084–1092CrossRef
19.
go back to reference Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg SM, Pacak K, Fojo T (2008) Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 113:2020–2028CrossRef Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg SM, Pacak K, Fojo T (2008) Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer 113:2020–2028CrossRef
20.
go back to reference O’Kane GM, Ezzat S, Joshua AM et al (2019) A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial. Br J Cancer 120:1113–1119CrossRef O’Kane GM, Ezzat S, Joshua AM et al (2019) A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial. Br J Cancer 120:1113–1119CrossRef
Metadata
Title
Functional Malignant Retroperitoneal Paraganglioma with Liver Metastasis: a Rare Case Report
Authors
Sachin S. Kadam
Sujai Hegde
Amol Galage
Tejaswini Kadam
Publication date
01-04-2021
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue Special Issue 1/2021
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-020-01259-4

Other articles of this Special Issue 1/2021

Indian Journal of Surgical Oncology 1/2021 Go to the issue